Medicus Pharma Ltd. — Form SCHEDULE 13D/A
Filed November 17, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
This is an amended Schedule 13D/A filing by Bokhari Raza regarding beneficial ownership in Medicus Pharma Ltd. (market cap ~$28.3M). The filing metadata shows it was filed November 17, 2026, but the actual amendment details—including specific share counts, percentages, acquisition dates, or what changed from the prior filing—are not disclosed in the metadata provided. Without access to the substantive document content (only headers and filing logistics are visible), no concrete ownership changes can be identified.
Why this rating
Schedule 13D filings are routine disclosure; substance unknown from metadata alone. Cannot assess materiality without actual amendment details.
See more from November 17, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.